drugset / Trial / NCT05383131

To Evaluate Drug-drug Interactions Between HEC585 and Pirfenidone or Nintedanib in Healthy Volunteers

NCT05383131

Phase 1 Completed 33 enrolled Sunshine Lake Pharma Co., Ltd.
Non-randomizedCrossoverOpen-labelTreatment

Summary

An open label study to evaluate drug-drug interactions between HEC585 and Pirfenidone or Nintedanib in healthy volunteers

Timeline

Start
2021-06-23
Primary completion
2021-11-30
Completion
2021-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject HEC585 Small molecule
Subject Nintedanib Small molecule
Subject Pirfenidone Small molecule